M&A

Why won’t Illumina sell Grail?
Medtech Dive
Wed, 04/5/23 - 10:06 am
Illumina
M&A
Grail
Carl Icahn
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
Mon, 04/3/23 - 03:33 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail
CNBC
Mon, 04/3/23 - 11:36 am
FTC
Illumina
Grail
competition
M&A
diagnostics
What M&A slowdown? Buyers circle GreenLight Biosciences, Egitis Therapeutics
Fierce Biotech
Fri, 03/31/23 - 11:53 am
M&A
GreenLight Biosciences
Egitis Therapeutics
venture capital
Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up
CNBC
Fri, 03/31/23 - 10:37 am
Illumina
Carl Icahn
Grail
M&A
CVS Health Completes $8 Bln Signify Health Acquisition
NASDAQ
Thu, 03/30/23 - 10:56 am
CVS Health
Signify Health
M&A
Are ICU Medical & GE HealthCare Competing to Acquire 2 Units from Medtronic?
Medical Devices and Diagnostics Industry
Wed, 03/29/23 - 04:20 pm
Medtronic
devices
Medtech
M&A
ICU Medical
GE Healthcare
Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs
Yahoo/Reuters
Tue, 03/28/23 - 10:18 am
Jounce Therapeutics
M&A
Concentra Biosciences
layoffs
CVS To Close Signify Health Deal, Launching A National In-Home Care Business
Forbes
Mon, 03/27/23 - 10:00 am
CVS Health
M&A
Signify Health
home healthcare
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
Sun, 03/26/23 - 03:44 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Sun, 03/26/23 - 03:36 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Baxter attracts Thermo Fisher, Celltrion as potential buyers for biopharma contracting business
Fierce Pharma
Tue, 03/21/23 - 10:03 pm
Baxter
Thermofisher
Celltrion
M&A
CMOs
Illumina, facing Icahn challenge, ‘moving quickly’ on resolution for Grail
BioPharma Dive
Mon, 03/20/23 - 04:42 pm
Illumina
Grail
M&A
Medtech
diagnostics
Carl Icahn
Pear Therapeutics Looks For A Buyer As It Struggles To Get Paid For Prescription Apps
Forbes
Sun, 03/19/23 - 01:40 pm
Pear Therapeutics
digital therapeutics
FDA
Medtech
insomnia
M&A
Concentra's Buy Offer May Jeopardize Jounce's Merger with Redx
BioSpace
Wed, 03/15/23 - 11:29 am
Jounce Therapeutics
Redx
Concerta
M&A
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
BioPharma Dive
Tue, 03/14/23 - 06:28 pm
FTC
Pfizer
Seagen
M&A
antitrust
anticompetitive practices
Pfizer CEO points to IRA as a factor that made Seagen an attractive target
Endpoints
Tue, 03/14/23 - 11:00 am
Pfizer
Seagen
M&A
Inflation Reduction Act
Illumina Responds to Icahn Partners' Nomination of Directors
BioSpace
Tue, 03/14/23 - 10:57 am
Illumina
Carl Icahn
M&A
Grail
Pfizer to buy Seagen in $43B cancer drug deal
BioPharma Dive
Mon, 03/13/23 - 10:57 am
Pfizer
Seagen
M&A
lymphoma
Adcetris

Pages